Evidence in favour
- Participation spans 15 named insiders rather than one filing source.
- The latest qualifying evidence is fresh, dated 10 Aug 2026.
Company insider dossier
Exelixis Inc insider intelligence
EXEL filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
26/100
Concentrated distribution
93/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Latest evidence
- 10 Aug 2026
Investment committee read
Concentrated distribution
Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.
Review exposure and filing contextDecision risks
- Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Feb 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 51.24 USD
- One-week move
- -5.2%
- Four-week move
- -8.4%
- Fair-value gap
- +49.0%
- Trend signal
- Active
- Relative strength
- -0.7
Directional balance
Controlled event mix
11.8%acquisition
- Acquisition events
- 2
- Disposal events
- 15
- Net value
- -$22.9M
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
201 Jun
008 Jun
015 Jun
022 Jun
029 Jun
006 Jul
013 Jul
020 Jul
027 Jul
003 Aug
110 Aug
017 Aug
Named participants
Insider conviction by person
FREIRE, MARIA CDirector612 events
HEYMAN, TOMAS J.Director500 events
JOHNSON, DAVID EDWARDDirector500 events
OLIVER, BOBDirector500 events
PAPADOPOULOS, STELIOSDirector500 events
SMITH, JULIEDirector500 events
BECKERLE, MARY CDirector393 events
ECKHARDT, SUE GAILDirector281 events
POSTE, GEORGEDirector281 events
WYSZOMIERSKI, JACK LDirector281 events
MORRISSEY, MICHAELDirector, President and CEO281 events
AFTAB, DANAEVP, Research and Development252 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable EXEL filing ledger
Showing 31 to 32 of 32.
BECKERLE, MARY CDirector
AcquisitionCommon equity
3856 sharesCommon Stock
$89.6KDirectional evidence
MORRISSEY, MICHAELDirector, President and CEO
DisposalCommon equity
109676 sharesCommon Stock
Not reportedContext evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.